• DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
      • Media workshops
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
      • Our story: 20 years of DNDi
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
  • DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
      • Media workshops
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
      • Our story: 20 years of DNDi
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
Home > News

DNDi Mourns the Loss of Jacques Pinel

Home > News

DNDi Mourns the Loss of Jacques Pinel

© Ludovic Weyland
17 Aug 2015

The Drugs for Neglected Diseases initiative (DNDi) extends its deepest condolences to the family of Jacques Pinel, who passed away on 14 August 2015.

As a pharmacist, Jacques Pinel was a pillar for Médécins Sans Frontières (MSF) since 1979. He was instrumental in setting up, rationalizing, and implementing all logistics, pharmacy, and medicines policy (including guidelines and emergency kits to name but a few) of MSF and beyond. In 1996, he led the movement of what was to become later the MSF Access Campaign. He later became a key member of the Drugs for Neglected Diseases working group, the precursor to DNDi. Indeed, he was staunch supporter of the creation of DNDi, advocating tirelessly within and outside of MSF. He has been an excellent advisor of the FACT project, which developed two fixed dose combinations of antimalarials. In his advisory role for FACT, Jacques can be accredited with the vital aspect of the patient-friendly packaging of ASAQ.

‘Without Jacques, DNDi would not be what it is today. As a friend and mentor, he will be sorely missed.’
– Bernard Pécoul

© Ludovic Weyland
Jacques Pinel at the MSF General Assembly, June 2011 © Ludovic Weyland

 

 

Read, watch, share

Loading...
Doctor speaking with a woman and her child
Press releases
22 Aug 2025

DNDi receives Japan’s Hideyo Noguchi Africa Prize 2025 for its work to develop new treatments for neglected diseases in Africa 

Dr Luis Pizarro delivering his acceptance address at the Hideyo Noguchi Africa Prize ceremony on 22 August 2025
News
22 Aug 2025

Acceptance address, Dr Luis Pizarro – Fifth Hideyo Noguchi Africa Prize Ceremony

Statements
21 Aug 2025

DNDi’s briefing note for the 75th Session of the World Health Organization Regional Committee for Africa

News
12 Aug 2025

DNDi calls for nominations for private sector Board member 

News
8 Aug 2025

Statement from DNDi on Kenya’s elimination of rhodesiense sleeping sickness as a public health problem 

News
5 Aug 2025

ADB and DNDi sign MoU to advance healthcare cooperation on neglected diseases in Asia and the Pacific

Press releases
23 Jul 2025

AN2 Therapeutics and DNDi collaborate on clinical development of promising new oral compound to treat chronic Chagas disease

Publications
15 Jul 2025

DNDi 2024 Annual Report

VIEW ALL

Help neglected patients

To date, we have delivered thirteen new treatments, saving millions of lives.

Our goal is to deliver 25 new treatments in our first 25 years. You can help us get there. 

GIVE NOW
Linkedin-in Instagram Twitter Facebook-f Youtube
International non-profit developing safe, effective, and affordable treatments for the most neglected patients.

Learn more

  • Diseases
  • Neglected tropical diseases
  • R&D portfolio
  • Policy advocacy

Get in touch

  • Our offices
  • Contact us
  • Integrity Line

Support us

  • Donate
  • Subscribe to eNews

Work with us

  • Join research networks
  • Jobs
  • RFPs
  • Terms of Use   
  •   Acceptable Use Policy   
  •   Privacy Policy   
  •   Cookie Policy   
  •   Our policies   

  • Except for images, films and trademarks which are subject to DNDi’s Terms of Use, content on this site is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 3.0 Switzerland License